Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.

Our immune system works to fight infections immediately, but also maintain long-term immunity. Two waves of protection help ...

INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...

New non-clinical data strengthens evidence of contributions of IO102 and IO103 to tumor growth control through target specific T-cell ...

Combining this with our previous findings on WNK1’s role in T cell migration, we are beginning to see a more complete picture of how immune cells quickly activate, move to where they’re needed ...